Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension

Pulmonary hypertension (PH) is characterized by a progressive elevation of mean arterial pressure followed by right ventricular failure and death. Previous studies have indicated that numerous inhibitors of receptor tyrosine kinase signaling could be either beneficial or detrimental for the treatmen...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Mol Sci
Auteurs principaux: Veeroju, Swathi, Kojonazarov, Baktybek, Weiss, Astrid, Ghofrani, Hossein Ardeschir, Weissmann, Norbert, Grimminger, Friedrich, Seeger, Werner, Novoyatleva, Tatyana, Schermuly, Ralph Theo
Format: Artigo
Langue:Inglês
Publié: MDPI 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7867319/
https://ncbi.nlm.nih.gov/pubmed/33540939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22031502
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires